Stacie Ann Chvatal

Title: Stacie Ann Chvatal: Innovator in Cell Culture Assessment

Introduction

Stacie Ann Chvatal is a prominent inventor based in Lawrenceville, GA (US). She has made significant contributions to the field of cell culture assessment, particularly in the context of electrically active cell cultures. With a total of 2 patents, her work is paving the way for advancements in scientific research and medical applications.

Latest Patents

Stacie's latest patents focus on systems and methods for assessing data collected from electrically active cell cultures. These innovations involve the use of microelectrode arrays (MEAs) to collect data from electrically active cells, such as cardiomyocytes. The methods she has developed aim to reduce the effects of confounding variables in data obtained from these cultures. Additionally, her patents provide a quantitative measure of arrhythmia burden and help determine the suitability of specific cultures for scientific studies. Furthermore, her work includes a method for finding the global conduction velocity of an electrically active cell culture.

Career Highlights

Stacie Ann Chvatal is currently employed at Axion Biosystems, Inc., where she continues to advance her research in cell culture technologies. Her innovative approaches have garnered attention in the scientific community, contributing to the understanding of cellular behavior and its implications for health and disease.

Collaborations

Stacie collaborates with notable colleagues, including Daniel Christopher Millard and James David Ross. Their combined expertise enhances the research efforts at Axion Biosystems, Inc., fostering a collaborative environment that drives innovation.

Conclusion

Stacie Ann Chvatal is a trailblazer in the field of cell culture assessment, with her patents reflecting her commitment to advancing scientific knowledge. Her work not only contributes to the understanding of electrically active cell cultures but also has the potential to impact various medical applications.